Immunic (IMUX) director receives 25,370 stock options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IMMUNIC, INC. director Richard Alan Rudick received a grant of stock options covering 25,370 shares of common stock as equity compensation. The options have an exercise price of $14.80 per share, vest in monthly increments over one year from the grant date, and expire on July 5, 2036. Following this award, he directly holds 25,370 derivative securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Rudick Richard Alan
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 25,370 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 25,370 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 25,370 options
Exercise price: $14.80 per share
Expiration date: July 5, 2036
+1 more
4 metrics
Stock options granted
25,370 options
Director Richard Alan Rudick equity award
Exercise price
$14.80 per share
Strike price for granted stock options
Expiration date
July 5, 2036
Option term end for this grant
Post-grant derivative holdings
25,370 derivative securities
Total options held directly after transaction
Key Terms
Stock Option, Grant, award, or other acquisition, exercise price, vesting
4 terms
Stock Option financial
"security_title: Stock Option"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 14.8000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests in monthly increments over a period of one year"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transaction did Immunic (IMUX) report for Richard Alan Rudick?
Immunic reported that director Richard Alan Rudick received a grant of stock options for 25,370 shares of common stock. This equity award was reported on a Form 4 as a compensation-related acquisition, not as an open-market purchase or sale.
What are the key terms of Richard Rudick’s new Immunic (IMUX) stock options?
Richard Rudick’s options cover 25,370 shares of Immunic common stock at an exercise price of $14.80 per share. They expire on July 5, 2036 and were granted at no upfront cost as a compensation-related stock option award.
How do Richard Rudick’s Immunic (IMUX) stock options vest over time?
The stock options granted to Richard Rudick vest in monthly increments over one year from the grant date. This means portions of the 25,370-share award become exercisable each month until fully vested after the one-year period.
Is Richard Rudick’s Immunic (IMUX) Form 4 transaction a stock purchase or sale?
The Form 4 reflects a grant of stock options classified as an acquisition, not an open-market stock purchase or sale. The transaction code “A” indicates a grant, award, or other acquisition of derivative securities, with no sale reported in this filing.
How many Immunic (IMUX) derivative securities does Richard Rudick hold after this grant?
After the stock option grant, Richard Rudick directly holds 25,370 derivative securities linked to Immunic common stock. These represent options that may be exercised at $14.80 per share before the stated expiration date, subject to vesting.